Atlas Trials

Argatroban for Preventing Occlusion and Restenosis After Intracranial and Extracranial Artery Stenting

Clinical trial NCT01163604 · COMPLETED

Trial details

NCT number
NCT01163604
Sponsor
Jinling Hospital, China
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
CVD
Start date
2010-08-01
Primary completion
2013-12-01
Enrollment
114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.